A Win For Ra Medical Systems, Inc.

Ra Medical Systems, Inc. (RMED:NYSE) soared at $9.14, representing a gain of 87.3%. On Fri, Jun 04, 2021, RMED:NYSE touched a New 2-Week High of $4.88. The stock appeared on our News Catalysts scanner on Tue, May 11, 2021 at 06:06 PM in the 'EARNINGS' category. From Fri, May 21, 2021, the stock recorded 66.67% Up Days and 80.00% Green Days

The stock spiked on Fri, Jun 04, 2021 at $7.64 with a volume of 36M+.

About Ra Medical Systems, Inc. (RMED:NYSE)

Ra Medical Systems Inc is a commercial-stage medical device company. It is engaged in designing, developing, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. The company's products include DABRA and Pharos. DABRA System is an effective, and versatile catheter and excimer laser system for the treatment of complex and diffuse arterial blockages in the lower vessels, and the Pharos is a monochromatic, xenon-chlorine, 308-nm UVB excimer laser for the treatment of difficult-to-treat, chronic diseases including psoriasis and vitiligo. Its business segments are the Dermatology segment and the Vascular segment. Generating, its revenue from the Dermatology segment.